WHAT'S KNOWN ON THIS SUBJECT: Jaundiced newborns without additional risk factors rarely develop kernicterus if the total serum bilirubin is ,25 mg/dL. Measuring the bilirubin/albumin ratio might improve risk assessment, but the relationships of both indicators to advancing stages of neurotoxicity are poorly documented.
METHODS:
A total of 193 term/near-term infants, admitted for severe jaundice to Cairo University Children's Hospital, were evaluated for neurologic status and auditory impairment (automated auditory brainstem response), both at admission and posttreatment by investigators blinded to laboratory results. The relationships of TSB and B/A to advancing stages of neurotoxicity were compared by using receiver operating characteristic curves.
RESULTS: TSB and B/A ranged from 17 to 61 mg/dL and 5.4 to 21.0 mg/g, respectively; 58 (30%) of 193 subjects developed acute bilirubin encephalopathy, leading to kernicterus in 35 infants (13 lethal) . Auditory impairment was identified in 86 (49%) of 173 infants at admission and in 22 of 128 at follow-up. In the absence of clinical risk factors, no residual neurologic or hearing impairment occurred unless TSB exceeded 31 mg/dl. However, transient auditory impairment occurred at lower TSB and B/A (22.9 mg/dL and 5.7 mg/g, respectively). Intervention values of TSB and B/A set at high sensitivity to detect different stages of neurotoxicity had nearly the same specificity.
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The American Academy of Pediatrics (AAP) guidelines for treating neonatal jaundice and preventing kernicterus in term/near-term infants are based on total serum bilirubin (TSB) levels adjusted for the absence or presence of clinical risk factors (eg, low gestational age [GA], sepsis, hemolytic disease). 1 Plasma free bilirubin (Bf) is thought to be a better indicator of neurotoxicity than TSB, because only Bf can cross the blood-brain barrier. 2, 3 In the absence of an available assay for Bf, the bilirubin/ albumin ratio (B/A) might provide a better estimate of Bf because it contains 2 of the 3 factors determining Bf (TSB, albumin, and the albuminbinding affinity). 2, 3 The relationship between Bf and B/A has been studied by titration of serum samples 4 and by measuring Bf in serum of infants with varying B/A, 5 but clinical evidence comparing the relationships of TSB and B/A with outcome is sparse. 6,7 B/A is currently recommended as a safeguard to identify the rare infant at risk for neurotoxicity at low TSB because of a low serum albumin concentration. 1 This study evaluated TSB and B/A as predictors of pretreatment and posttreatment auditory and neurologic impairment in infants with severe hyperbilirubinemia. We hypothesize that B/A is a better predictor of bilirubin toxicity than TSB. A secondary hypothesis is that advancing stages of bilirubin neurotoxicity have increasing threshold values for TSB and B/A.
METHODS

General Study Design
This prospective longitudinal observational study was performed at Cairo University Children' s Hospital. Infants admitted with severe hyperbilirubinemia received serial neurologic evaluations using a standard examination for grading the severity of bilirubininduced neurologic dysfunction (BIND score; Appendix 1). 8 Auditory function was assessed with the automated auditory brainstem response (AABR) device (Algo3i; Natus Medical, Inc, San Carlos, CA). 9 AABRs were obtained within 2 hours of admission and at discharge in most patients. Follow-up evaluation at 3 to 5 months included both a neurologic examination 10 and repeat AABR.
Treatment decisions were made by attending physicians blinded to AABR and BIND score data. Criteria for exchange transfusion were a TSB level $25 mg/dL, presence of neurologic signs, or a rapid rise of TSB on day 1. Investigators calculating BIND score, performing AABRs, and conducting follow-up assessments were blinded to laboratory data and were not involved in patient management.
Subjects
A total of 224 newborns were enrolled in a study evaluating risk factors for bilirubin encephalopathy between June 2009 and October 2010. Entry criteria included infants #14 days old with severe jaundice requiring intensive phototherapy or exchange transfusion and an estimated GA $34 weeks (using the New Ballard Score). 11 We analyzed a subcohort of 193 infants after excluding infants with missing albumin data (23 cases), inadequate outcome documentation (4 cases), or comorbid conditions unrelated to jaundice (4 cases). The study was approved by institutional review boards at participating universities, and parental informed consents were obtained for all infants.
Laboratory Analysis
TSB and albumin levels were determined in the clinical laboratory at Cairo University Children's Hospital. TSB was measured by the Doumas modification of the Jendrassik-Grof diazo method 12 and albumin by the bromocresol purple method 13 by using a Dimension RxL analyzer (Siemens Healthcare Diagnostics Inc, Tarrytown, NY). Quantitative glucose-6-phosphate dehydrogenase (G6PD) assay was performed at 3 to 5 months by using a G6PDH kit (Trinity Biotech, Bray, Ireland). Deficiency was defined as G6PD activity ,6.4 U/g hemoglobin.
Outcome Definitions
Overt acute bilirubin encephalopathy (ABE) is defined as a BIND score of 4 to 9. The BIND score 7 describes the progression of ABE. Scores of 4 to 6 represent moderate ABE, and scores of 7 to 9 indicate severe ABE that is highly associated with kernicterus or death. 8, [14] [15] [16] Infants with BIND scores of 1 to 3 are referred to as having mild neurotoxicity or mild ABE that is likely to be reversible without sequelae.
Posttreatment diagnosis of kernicterus required 1 of the following criteria: death from severe ABE, neurologic findings of kernicterus at follow-up as described by Shapiro, 10 or persistent severe encephalopathy and bilateral refer (RR) AABR at hospital discharge for infants lost to followup. MRI examinations were not performed.
Auditory impairment was defined as a bilateral "refer for further evaluation" result (RR AABR). Bilateral pass or unilateral pass was considered "normal." Admission AABRs were usually unsuccessful in severely affected infants due to muscle activity. If the BIND score was 6 to 9 and the infant died of kernicterus or had RR AABR at discharge, the unsuccessful admission AABR was considered to be RR for statistical analysis.
A diagnostic evaluation for auditory neuropathy [17] [18] [19] was performed if the AABR screen was RR at 3 to 5 months. Compliance with follow-up appointments was 74.5%.
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Definition of Clinical Risk Factors
Hemolysis was arbitrarily defined as hematocrit #35% with increased reticulocytes ($6%) in patients with possible isoimmunization. Suspected sepsis was defined as clinical deterioration in the presence of leukocytosis, leucopenia, shift to the left of neutrophils, and a positive C-reactive protein screen. 20 The accuracy of GA assessment 11 was limited by the patient' s postnatal age and occasional illness at admission. Birth weights were rarely available; accuracy of GA was limited by postnatal age at admission and confounded by disease in some infants. Historically, birth weights . or #2500 g have been used to assess risk due to maturity. 4, 21 Because birth weights were unavailable and GA often uncertain, we used admission weight (. or #2500 g), the only objective measure available, to assign risk related to maturity
Statistical Methods
The initial TSB and B/A were used to predict admission BIND scores and AABR results. Occasionally, blood for exchange transfusion was delayed; therefore, peak TSB and peak B/A before exchange transfusion were used to predict subsequent outcomes.
Quantitative biochemical data were not normally distributed. Data were summarized as medians, interquartile (25th-75th percentile) and total ranges, and compared by using Mann-Whitney U and Kruskal-Wallis tests. 22 Qualitative data were presented as frequency and percentage. Sensitivities and specificities associated with different cutoff values for TSB and B/A were evaluated by using receiver operating characteristic (ROC) curves. 23 Calculations were performed by using the IBM SPSS (version 20) program (IBM SPSS Statistics, IBM Corporation, Chicago, IL). For some analyses, subjects were stratified by the presence or absence of possible clinical risk factors.
RESULTS
Patient Characteristics
Although 87% of infants were delivered at hospitals, newborns were usually discharged several hours after birth without evaluation for jaundice or scheduled follow-up. 24 Birth weight, GA, and blood type incompatibilities were rarely documented at the birthing hospital. The median age at admission to the NICU was 4.5 days. Admission TSB was #25.0 mg/dL in 41 infants, 25.1 to 35.0 mg/dL in 117 infants, and .35.0 mg/dL in 35 infants. Patient characteristics are summarized in Table 1 .
Clinical Risk Factors
In this cohort, 59 (30.6%) newborns had no risk factors other than severe hyperbilirubinemia. Possible clinical risk factors were present in 134 infants (69.4%), but confidence in assigning risk was often lacking. Fifty-eight infants weighed #2500 g, but it was sometimes unclear whether they were immature or small for GA.
A total of 103 infants had ABO incompatibility, but there was no evident relationship between incompatibility, hematocrit, reticulocyte count, direct antiglobulin test, and magnitude of hyperbilirubinemia. G6PD deficiency was identified in 10 of 134 patients tested at follow-up, but only 1 had evidence of a hemolytic crisis at admission. Blood cultures were positive in 4 of 12 infants with suspected sepsis.
Because clinical risk factors were uncertain in a large fraction of subjects, we used both nonstratified data and data dichotomized for absence or presence of possible risk factors for analyses.
Patient Management
All patients received phototherapy (irradiance ,20 mW/cm 2 /nm). Exchange transfusions were performed in 147 patients (76.2%), including all infants admitted with ABE (BIND scores 4-9). However, 66% of infants with no or mild ABE received exchange transfusion because of TSB .25 mg/dL. Median TSB and B/A values in infants receiving exchange transfusion were 32.2 mg/dL and 9.7 mg/g, respectively, compared with TSB 25.1 mg/dL and B/A 7.7 mg/g in those receiving only phototherapy. Blood was not available for exchange transfusion in 3 infants with TSBs 30.0 to 33.6 mg/dL, but they 
Outcomes
At admission, 25 infants suffered moderate ABE (BIND 4-6). Among 22 of those 25 infants attending follow-up, 13 were healthy, 5 had isolated auditory neuropathy, and 4 had frank kernicterus. Severe ABE (BIND score 7-9 at admission) occurred in 33 infants. Two infants with BIND score of 7, lost to follow-up, were neurologically healthy at discharge but had RR AABR. The remaining 31 infants (94%) had adverse outcomes compared with only 9 (41%) of 22 infants with moderate encephalopathy Kernicterus was diagnosed in 35 cases; 13 infants died with severe ABE in hospital, 17 had frank kernicterus 10 at follow-up, and 5 infants, lost to followup, had signs of persistent bilirubin encephalopathy at discharge. All infants with kernicterus had BIND scores of 5 to 9 while hospitalized, and all received exchange transfusion (see Appendix 2 for details).
At admission, the AABR was RR in 86 (50%) of 173 tests performed. A total of 128 surviving infants were evaluated at follow-up. Sixty percent of infants with admission RR AABR converted to bilateral pass, whereas 22 infants had persistent RR AABR confirmed to be auditory neuropathy by diagnostic audiology procedures. [17] [18] [19] All infants with maximum TSB ,31 mg/dL and BIND score #3 had normal auditory function at follow-up.
Relationships of TSB and B/A to Outcomes
We found a clear stepwise relationship between TSB and B/A median and threshold values and the progression of acute neurotoxicity (Table 2 ). There was a large gap in thresholds separating mild ABE (20.0 mg/dLTSB, 5.5 mg/g B/A) and moderate ABE (27.1 mg/dL, 7.1 mg/g). A smaller increase was noted between thresholds for moderate and severe ABE. Two of 4 infants admitted at ,24 hours of age with rapidly rising TSB (18.7 and 24.0 mg/dL) had refer AABRs, and 1 had a BIND score of 5. Because the response to rapidly rising bilirubin was unique in these infants, infants admitted at ,1 day of age were excluded from group analyses.
Subjects were not stratified for risk factors, so results in Table 2 include patients at the highest clinical risk category defined in the AAP guidelines. 1 At all stages of toxicity, TSBs identifying 100% of diseased infants were higher than the recommended intervention guideline for high-risk infants ,38 weeks' GA 1 (TSB 19.0 mg/dL), but B/A thresholds for mild neurotoxicity (BIND scores 2-3) and AABR RR at admission were lower than the AAP recommendation (6.8 mg/dL). 
ROC Analysis
We compared sensitivities and specificities of TSB and B/A in identifying acute and posttreatment outcomes by using ROC curves (Fig 1) . ROC curves describe the specificity of a diagnostic test at any selected sensitivity (and vice versa). For all outcomes, the area under the curve for TSB is slightly higher than for B/A, and significantly higher for auditory impairment at admission. There is almost no crossover of ROC curves for TSB and B/A in any outcome prediction (ie, at any given sensitivity, the specificity of TSB is equal to or slightly better than B/A). Table 3 lists TSB and B/A cutoff values yielding 100% sensitivity together with specificities and confidence intervals for various stages of neurotoxicity in our study population. Calculated cutoffs are consistent with threshold values described in Table 2 . 
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DISCUSSION
Any criterion for intervention in hyperbilirubinemia must have a high sensitivity, identifying all or nearly all infants with a possibility of permanent injury. In this study, both TSB and B/A were strong predictors of acute and residual encephalopathy, but when B/A and TSB intervention levels were selected to yield the same sensitivity, B/A did not improve discrimination of patients at risk as hypothesized. This does not mean that measuring serum albumin is unimportant. Severe hemolytic disease and capillary leak from avariety of conditions can result in plasma albumin depletion. In such infants, the risk for kernicterus may occur at TSB levels well below AAP-recommended intervention levels for sick infants, 25 but the B/A cutoff would be breeched.
Role of Risk Factors
Proposed clinical risk factors for bilirubin toxicity 1 had surprisingly little influence on either threshold or median values of TSB and BA 
